Dr Bernado Rapoport presents...

Dr Bernado Rapoport presents Dr Bernado Rapoport presenting his poster on “Prevention of chemotherapy induced nausea and vomiting (CINV), efficacy and safety of Rolapitant over multiple cycles of highly or moderately emetogenic chemotherapy."

< Click image for larger version.


European Cancer Congress 2015 (ECC 2015)

Vienna, Austria - 25 Sep - 29 Sep 2015

The European Cancer Congress (ECC 2015) is a biennial congress which combines the efforts of the most important European oncology professionals with the aim of improving the prevention, diagnosis, treatment and care of cancer patients.

Read more ...

Membership Fees

At our extra ordinary AGM in 2014 a change in the Constitution of SASMO now has 2 stratifications for members either a Full Member with full voting rights (people qualifying for this need to be Registered Medical Oncologists) and Associate Members who are Allied/Interested Parties who will not have voting rights.

Your membership fees for SASMO have now become due. This letter serves to inform you that the Membership fees will increase to R1000-00 for a period of 4 years membership as of 2015 for Full Members with full voting rights (Registered Medical Oncologists) and for Associated members the fee will be R500-00 for a 4 year period.

Read more ...

ESMO 2014 Congress

ROMANA 1 and 2

ROMANA 1 and 2, two phase 3 trials, have assessed the efficacy and safety of anamorelin hydrochloride, a selective ghrelin receptor agonist, in patients with cancer anorexia-cachexia and unresectable stage III/1V non-small-cell lung cancer (NSCLC). Patients were randomly assigned (2:1) to either anamorelin or placebo.

Read more ...